The objective of this study is to evaluate whether there are different clinical outcomes and unscheduled follow-ups between in-person and telemedicine medication abortion, and to better understand patients' experiences with telemedicine medication abortion and their motivations for seeking unscheduled follow-up care in a setting where abortion care, including both virtual and in-person follow-up care, is readily accessible.
This study will be retrospective chart review comparing clinical and demographic characteristics, eligibility, treatment success, participation in unscheduled and scheduled follow-ups, and adverse events of patients who obtained a telemedicine medication abortion through the Telehealth Medication Abortion Clinic with patients who received an in-person medication abortion provided at the Family Planning Faculty Practice from June 2023 through September 2024.
Study Type
OBSERVATIONAL
Enrollment
400
Meeting with a clinician via video visit to determine if patient is eligible for medication abortion without pre-treatment ultrasound or laboratory testing. If eligible, the patient travels to clinic to pick up medications in person.
Columbia University Irving Medical Center
New York, New York, United States
Number of unscheduled follow-ups
If patients engaged in follow-up are outside of their routinely scheduled follow-up visit 1-2 weeks after medication abortion
Time frame: 3 months after initial encounter
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.